Filing Flows

Filing Flows › Companies › Stereotaxis › Cash flow

Stereotaxis cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$3.7M in Q2 2026 · −$15.5M over twelve months

Operating cash flow−$3.7M
Capital spending−$64K
Free cash flow−$3.7M
Cash conversion cycle238 days

Analysis

In Q2 2026, Stereotaxis generated −$3.7M of operating cash flow and spent $64K on capital projects, leaving free cash flow of −$3.7M. That is $6K less than in Q2 2025 (−$3.7M).

Over the twelve months to Jun 30, 2026, operating cash flow was −$15.3M; the largest uses were operating cash flow ($15.3M), other financing ($1.1M), other investing ($1.1M); besides operations, cash came from shares issued ($21.2M); the cash balance rose by $3.5M.

Operating cash flow was −$3.7M against net income of −$4.5M. The largest differences: payables +$2.1M, inventory −$2.0M, stock-based pay +$1.6M.

Its cash conversion cycle was 238 days (receivables 76 + inventory 329 − payables 167).

Free cash flow

Stereotaxis: free cash flow by quarterStereotaxis: free cash flow by quarter−$4.3MQ3 2024$1.3MQ4 2024−$1.8MQ1 2025−$3.7MQ2 2025−$4.2MQ3 2025−$4.0MQ4 2025−$3.5MQ1 2026−$3.7MQ2 2026
Operating cash flow less capital spending.
Stereotaxis: operating cash flow against capital spendingStereotaxis: operating cash flow against capital spendingOperating cash flowCapital spending−$4.3M$10KQ3 2024$1.3M$2KQ4 2024−$1.8M$0Q1 2025−$3.7M$0Q2 2025−$4.2M$0Q3 2025−$4.0M$70KQ4 2025−$3.4M$79KQ1 2026−$3.7M$64KQ2 2026
Latest (Q2 2026): Operating cash flow −$3.7M, Capital spending $64K.

Capital allocation, year by year

Stereotaxis: where the cash came from (up) and went (down), by fiscal yearStereotaxis: where the cash came from (up) and went (down), by fiscal yearOperating cash flowShares issuedCapital spendingFY2021: Operating cash flow −$2.9MFY2021: Shares issued $547KFY2021: Capital spending −$1.4M$547KFY2021FY2022: Operating cash flow −$8.4MFY2022: Shares issued $220KFY2022: Capital spending −$2.4M$220KFY2022FY2023: Operating cash flow −$9.1MFY2023: Shares issued $81KFY2023: Capital spending −$366K$81KFY2023FY2024: Operating cash flow −$8.5MFY2024: Shares issued $297KFY2024: Capital spending −$34K$297KFY2024FY2025: Operating cash flow −$13.7MFY2025: Shares issued $15.7MFY2025: Capital spending −$93K$15.7MFY2025
Over these 5 years operating cash flow totalled −$42.7M; the largest uses were operating cash flow ($42.7M) and capital spending ($4.3M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$10.5M
Debtnone
Net cash$10.5M
Cash runway8 months

Stereotaxis is burning cash: its operations consume cash, a free cash flow of −$15.5M a year at the current rate against $10.5M of cash and investments: a runway of about 8 months before any new financing.

Where the cash came from and went

Stereotaxis: sources (+) and uses (−) of cash, Q2 2026Stereotaxis: sources (+) and uses (−) of cash, Q2 2026Cash drawn (+) / kept (−)$4.1MOperating cash flow−$3.7MOther investing−$1.1MShares issued$771KOther financing−$76KCapital spending−$64K
Stereotaxis: sources (+) and uses (−) of cash, TTM to Q2 2026Stereotaxis: sources (+) and uses (−) of cash, TTM to Q2 2026Shares issued$21.2MOperating cash flow−$15.3MCash drawn (+) / kept (−)−$3.5MOther financing−$1.1MOther investing−$1.1MCapital spending−$213K

From profit to cash

Stereotaxis: net income to operating cash flow, Q2 2026Stereotaxis: net income to operating cash flow, Q2 2026Net income−$4.5MDepreciation & amortization$407KStock-based pay$1.6MReceivables−$1.2MInventory−$2.0MPayables$2.1MAccrued liabilities−$153KDeferred revenue−$751KPrepaid and other assets$186KOperating cash flow−$3.7M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q2 202676329167238
Q1 202680362173268
Q4 202560210101169
Q3 202560270156174
Q2 202545209143111
Q1 202549240161127
Q4 202485255178163
Q3 20245416595123

Every quarter

QuarterOperating cash flowCapital spendingShares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026−$3.7M−$64K$771K$4.1M−$3.7M
Q1 2026−$3.4M−$79K$4.9M−$1.2M−$3.5M
Q4 2025−$4.0M−$70K$7.8M−$2.9M−$4.0M
Q3 2025−$4.2M—$7.7M−$3.5M−$4.2M
Q2 2025−$3.7M—$34K$3.7M−$3.7M
Q1 2025−$1.8M—$32K$1.7M−$1.8M
Q4 2024$1.3M−$2K$159K−$1.4M$1.3M
Q3 2024−$4.3M−$10K$80K$4.2M−$4.3M

Stereotaxis: income statement and cash flow

Stereotaxis, Q2 2026: revenue $7.7M (-13% year over year), operating margin -59.6%. The chart follows the revenue to costs, profit and cash.

Stereotaxis: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.